IART
INTEGRA LIFESCIENCES HOLDINGS CORP
NASDAQ · Healthcare · Medical - Devices · US
$14.58
+6.93%Year over year
Reported trailing growth
- Revenue
- +0.8%
- EBITDA
- +174.8%
- EBIT
- +240.3%
- EPS
- +102.6%
- Free cash flow
- +782.5%
- Operating cash flow
- +57.2%
Forward estimates
Based on analyst estimates
- Revenue
- +0.0%
- EBITDA
- +105.5%
- EPS
- +1289.4%
Three-year CAGR
- Revenue
- +1.6%
- EBITDA
- —
- EBIT
- -34.1%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026